[HTML][HTML] Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

…, A Stefos, S Georgiadou, V Lygoura… - The Lancet …, 2021 - thelancet.com
Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …

An open label trial of anakinra to prevent respiratory failure in COVID-19

…, V Petrakis, K Tsiakos, M Kosmidou, V Lygoura… - Elife, 2021 - elifesciences.org
Background: It was studied if early suPAR-guided anakinra treatment can prevent severe
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …

Prompt initiation of high‐dose iv corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis

…, P Arvaniti, K Azariadis, V Lygoura… - Hepatology …, 2019 - Wiley Online Library
Aims The definition of original acute severe autoimmune hepatitis (AS‐AIH) is unclear. However,
its rapid recognition and early treatment is potentially life‐saving. Therefore, we present …

Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece

NK Gatselis, K Zachou, V Lygoura, K Azariadis… - European Journal of …, 2017 - Elsevier
Background & aims Primary biliary cholangitis (PBC) is a disease with rising prevalence
and considerable geographical variation. To describe the prevalence, spatial and time …

[HTML][HTML] Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis

A Laschtowitz, K Zachou, V Lygoura, S Pape, F Derben… - JHEP Reports, 2021 - Elsevier
Background & Aims In autoimmune hepatitis (AIH), normal levels of transaminases and IgG
define biochemical remission and are considered the best surrogate markers for histological …

[HTML][HTML] Innate immune gene polymorphisms and COVID-19 prognosis

…, E Asvestopoulou, S Alexiou, E Botsfari, V Lygoura… - Viruses, 2023 - mdpi.com
COVID-19 is characterized by a heterogeneous clinical presentation and prognosis. Risk
factors contributing to the development of severe disease include old age and the presence of …

[HTML][HTML] Soluble IL-2R levels at baseline predict the development of severe respiratory failure and mortality in COVID-19 patients

NK Gatselis, V Lygoura, A Lyberopoulou, G Giannoulis… - Viruses, 2022 - mdpi.com
Risk stratification of coronavirus disease-19 (COVID-19) patients by simple markers is
critical to guide treatment. We studied the predictive value of soluble interleukin-2 receptor (sIL-2R…

Autoimmune hepatitis in patients aged 70 years or older: disease characteristics, treatment response and outcome

GN Dalekos, K Azariadis, V Lygoura… - Liver …, 2021 - Wiley Online Library
Background & Aims Autoimmune hepatitis (AIH) affects both sexes and all age groups. However,
very few studies have focused specifically on the characteristics and outcome of AIH in …

Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with …

GN Dalekos, A Stefos, S Georgiadou, V Lygoura… - European Journal of …, 2021 - Elsevier
Aims Infection by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) may lead
to the development of severe respiratory failure. In hospitalized-patients, prompt interruption …

[HTML][HTML] FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseases

K Zachou, V Lygoura, P Arvaniti, G Giannoulis… - Annals of hepatology, 2021 - Elsevier
Introduction and Objectives We assessed FibroMeter virus (FMvirus) and FibroMeter
vibration-controlled transient elastography (FMVCTE) in 134 patients with autoimmune liver …